We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UWMC icon
6326
UWM Holdings
UWMC
$631M
$115K ﹤0.01%
16,517
-198,953
-92% -$1.48M
PHLT
6327
DELISTED
Performant Healthcare Inc
PHLT
$115K ﹤0.01%
29,066
-86,949
-75% -$384K
USIO icon
6328
Usio Inc
USIO
$59.1M
$114K ﹤0.01%
+19,257
New +$112K
FSTX
6329
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$114K ﹤0.01%
+15,547
New +$107K
WARR.WS
6330
CALL
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
$114K ﹤0.01%
207,850
+149,325
+255% +$101K
YELL
6331
DELISTED
Yellow Corporation Common Stock
YELL
$114K ﹤0.01%
20,130
-378,552
-95% -$2.2M
PEI
6332
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$114K ﹤0.01%
+3,926
New +$120K
ANY icon
6333
Sphere 3D
ANY
$18M
$113K ﹤0.01%
+271
New +$87K
NVNO
6334
enVVeno Medical
NVNO
$7.1M
$113K ﹤0.01%
+311
New +$80.5K
RCAT icon
6335
Red Cat Holdings
RCAT
$1.12B
$113K ﹤0.01%
+32,362
New +$100K
VIVO
6336
VivoPower PLC
VIVO
$109M
$113K ﹤0.01%
2,001
+929
+87% +$56.6K
SVFA
6337
CALL
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$112K ﹤0.01%
112,080
EQHA.WS
6338
CALL
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$112K ﹤0.01%
192,500
+167,500
+670% +$106K
MN
6339
DELISTED
MANNING & NAPIER, INC.
MN
$112K ﹤0.01%
12,301
-26,865
-69% -$243K
SLS icon
6340
SELLAS Life Sciences
SLS
$2.02B
$111K ﹤0.01%
+12,161
New +$113K
SPKB
6341
CALL
DELISTED
Silver Spike Acquisition Corp II Class A Ordinary Shares
SPKB
$111K ﹤0.01%
102,499
JOFFW
6342
CALL
DELISTED
JOFF Fintech Acquisition Corp. Warrant
JOFFW
$111K ﹤0.01%
171,422
-112,956
-40% -$90.2K
NMMCW
6343
CALL
DELISTED
North Mountain Merger Corp. Warrant
NMMCW
$111K ﹤0.01%
+125,000
New +$112K
SPI
6344
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$111K ﹤0.01%
+22,057
New +$121K
INO icon
6345
Inovio Pharmaceuticals
INO
$54M
$110K ﹤0.01%
+1,276
New +$128K
GGMCW
6346
CALL
DELISTED
Glenfarne Merger Corp. Warrant
GGMCW
$110K ﹤0.01%
164,400
+31,101
+23% +$24.5K
NES
6347
DELISTED
Nuverra Environmental Solutions, Inc. Common Stock
NES
$110K ﹤0.01%
55,538
-5,515
-9% -$12.1K
AIM
6348
AIM ImmunoTech
AIM
$6.52M
$110K ﹤0.01%
+544
New +$110K
CELU icon
6349
Celularity
CELU
$19.7M
$109K ﹤0.01%
1,539
-40,984
-96% -$3.31M
NCV
6350
Virtus Convertible & Income Fund
NCV
$380M
$109K ﹤0.01%
+4,571
New +$111K

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.